Trial Outcomes & Findings for Safety Study of Quickclot for Bleeding Control After Adenotonsillectomy (NCT NCT01863563)

NCT ID: NCT01863563

Last Updated: 2019-03-26

Results Overview

After removal of the adenoids, a tonsil pack wrapped in QuikClot will be placed in the nasopharynx. The investigators will then perform tonsillectomy with the Microdebrider. A QuikClot roll will be placed in the tonsil fossa, and pressure applied via tonsil sponge for one minute. The contralateral tonsil will then be addressed with the same technique. The QuikClot adenoid pack is then removed and residual adenoidal bleeding is addressed with suction electrocautery, followed by placement of a second QuikClot adenoid pack. The tonsil rolls are sequentially removed, followed by control of residual hemostasis with suction electrocautery. A second set of tonsil rolls are placed. After adenoid pack is removed from nasopharynx and bleeding controlled, tonsil rolls are removed, followed by suction electrocautery for any residual hemostasis is performed.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

100 participants

Primary outcome timeframe

at the time of surgery, 1 hour

Results posted on

2019-03-26

Participant Flow

Tertiary children's hospital enrolled 100 consectutive children

Participant milestones

Participant milestones
Measure
QuickClot
single dose
Overall Study
STARTED
100
Overall Study
COMPLETED
100
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Safety Study of Quickclot for Bleeding Control After Adenotonsillectomy

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Quickclot
n=100 Participants
QuickClot sponge will be applied for one minute each site of tonsillectomy and Adenoidectomy
Age, Categorical
<=18 years
100 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
Age, Continuous
4.8 years
STANDARD_DEVIATION 3.7 • n=5 Participants
Sex: Female, Male
Female
48 Participants
n=5 Participants
Sex: Female, Male
Male
52 Participants
n=5 Participants
Region of Enrollment
United States
100 participants
n=5 Participants

PRIMARY outcome

Timeframe: at the time of surgery, 1 hour

After removal of the adenoids, a tonsil pack wrapped in QuikClot will be placed in the nasopharynx. The investigators will then perform tonsillectomy with the Microdebrider. A QuikClot roll will be placed in the tonsil fossa, and pressure applied via tonsil sponge for one minute. The contralateral tonsil will then be addressed with the same technique. The QuikClot adenoid pack is then removed and residual adenoidal bleeding is addressed with suction electrocautery, followed by placement of a second QuikClot adenoid pack. The tonsil rolls are sequentially removed, followed by control of residual hemostasis with suction electrocautery. A second set of tonsil rolls are placed. After adenoid pack is removed from nasopharynx and bleeding controlled, tonsil rolls are removed, followed by suction electrocautery for any residual hemostasis is performed.

Outcome measures

Outcome measures
Measure
Cauterization Time
n=100 Participants
single dose
Total Suction Electrocautery Time Required for Hemostasis Will be Recorded as Seconds
tonsil cauterization time
94.5 seconds
Standard Deviation 41.9
Total Suction Electrocautery Time Required for Hemostasis Will be Recorded as Seconds
total cauterization time
155.3 seconds
Standard Deviation 59.7
Total Suction Electrocautery Time Required for Hemostasis Will be Recorded as Seconds
adenoid cauterization time
60.9 seconds
Standard Deviation 31.5

Adverse Events

Adverse Events

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Craig Derkay, MD

Children's Hospital of the Kings Daughters

Phone: 757.668. 9327

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place